Advertisement

Topics

RXi Pharma Advances Immuno-Oncology Pipeline By Selecting Two sd-rxRNA Compounds For Preclinical Development And Sourcing cGMP Manufacturing

20:00 EDT 7 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: RXi Pharma Advances Immuno-Oncology Pipeline By Selecting Two sd-rxRNA Compounds For Preclinical Development And Sourcing cGMP Manufacturing

NEXT ARTICLE

More From BioPortfolio on "RXi Pharma Advances Immuno-Oncology Pipeline By Selecting Two sd-rxRNA Compounds For Preclinical Development And Sourcing cGMP Manufacturing"

Quick Search
Advertisement